US Stock MarketDetailed Quotes
HCTI Healthcare Triangle
- 0.5653
- +0.0233+4.30%
Close Aug 23 16:00 ET
- 0.5601
- -0.0052-0.92%
Post 17:22 ET
3.20MMarket Cap-234P/E (TTM)
0.5980High0.5400Low29.64KVolume0.5900Open0.5420Pre Close16.63KTurnover1.02%Turnover RatioLossP/E (Static)5.67MShares4.870052wk High-4.96P/B1.65MFloat Cap0.431352wk Low--Dividend TTM2.92MShs Float43.5000Historical High--Div YieldTTM10.70%Amplitude0.4313Historical Low0.5600Avg Price1Lot Size
Healthcare Triangle Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -65.00%2.98M | -58.23%4.11M | -27.64%33.2M | -37.48%7.06M | -34.90%7.78M | -26.42%8.53M | -11.02%9.84M | 30.10%45.89M | 22.89%11.29M | 47.93%11.95M |
| Operating revenue | -65.00%2.98M | -58.23%4.11M | -27.64%33.2M | -37.48%7.06M | -34.90%7.78M | -26.42%8.53M | -11.02%9.84M | 30.10%45.89M | 22.89%11.29M | 47.93%11.95M |
| Cost of revenue | -68.29%2.09M | -62.46%3.1M | -23.60%26.43M | -41.65%5.53M | -28.75%6.07M | -21.95%6.58M | 1.02%8.25M | 39.77%34.59M | 36.99%9.48M | 59.23%8.52M |
| Gross profit | -53.88%898K | -36.35%1.01M | -40.00%6.78M | -15.66%1.53M | -50.20%1.71M | -38.37%1.95M | -44.96%1.59M | 7.35%11.3M | -20.09%1.81M | 25.75%3.43M |
| Operating expense | -35.74%2.28M | -43.32%2.72M | -16.52%18.13M | -0.40%6.55M | -43.07%3.23M | -22.87%3.54M | -1.36%4.8M | 36.72%21.71M | 17.24%6.58M | 26.22%5.68M |
| Selling and administrative expenses | -41.81%1.54M | -39.24%2.06M | -18.49%10.09M | -44.66%1.6M | -25.19%2.47M | -14.96%2.64M | 9.64%3.39M | 34.58%12.38M | -13.27%2.9M | 58.34%3.3M |
| -Selling and marketing expense | -38.50%631K | -49.86%883K | -31.40%4.67M | -51.19%782K | -39.34%1.1M | -37.86%1.03M | 1.21%1.76M | 43.00%6.81M | -18.27%1.6M | 36.67%1.82M |
| -General and administrative expense | -43.92%904K | -27.76%1.18M | -2.71%5.42M | -36.58%820K | -7.84%1.36M | 11.10%1.61M | 20.50%1.63M | 25.56%5.58M | -6.17%1.29M | 96.55%1.48M |
| Research and development costs | 102.94%207K | -76.44%127K | -86.58%799K | -96.25%104K | -96.33%54K | -84.21%102K | -49.44%539K | 13.26%5.95M | 86.98%2.77M | -33.26%1.47M |
| Depreciation amortization depletion | -33.42%534K | -38.67%536K | 114.34%7.23M | 432.31%4.84M | -21.67%712K | -4.98%802K | 22.93%874K | 137.27%3.37M | 15.34%910K | 330.81%909K |
| -Depreciation and amortization | -33.42%534K | -38.67%536K | 114.34%7.23M | 432.31%4.84M | -21.67%712K | -4.98%802K | 22.93%874K | 137.27%3.37M | 15.34%910K | 330.81%909K |
| Operating profit | 13.61%-1.38M | 46.77%-1.71M | -8.95%-11.35M | -5.42%-5.02M | 32.18%-1.52M | -11.30%-1.6M | -62.56%-3.21M | -94.40%-10.42M | -42.62%-4.76M | -26.95%-2.25M |
| Net non-operating interest income expense | 29.57%-131K | -140.32%-149K | -356.60%-968K | -267.47%-305K | -654.55%-415K | -220.69%-186K | -287.50%-62K | 62.61%-212K | 4.60%-83K | 75.11%-55K |
| Non-operating interest expense | -29.57%131K | 140.32%149K | 356.60%968K | 267.47%305K | 654.55%415K | 220.69%186K | 287.50%62K | -62.61%212K | -4.60%83K | -75.11%55K |
| Other net income (expense) | -98.89%12K | 0 | 12K | 1.08M | -6K | |||||
| Special income (charges) | ---- | ---- | -98.89%12K | --0 | ---- | ---- | ---- | --1.08M | ---6K | ---- |
| -Less:Other special charges | ---- | ---- | 98.89%-12K | --0 | ---- | ---- | ---- | ---1.08M | --6K | ---- |
| Other non- operating income (expenses) | ---- | ---- | ---- | ---- | ---- | ---- | --12K | ---- | ---- | ---- |
| Income before tax | 15.27%-1.51M | 43.02%-1.86M | -28.88%-12.3M | -9.77%-5.33M | 15.77%-1.94M | -340.84%-1.78M | -63.77%-3.26M | -61.13%-9.55M | -41.59%-4.85M | -15.62%-2.3M |
| Income tax | -80.00%1K | -73.68%5K | -44.44%35K | -41.67%7K | -89.19%4K | 400.00%5K | -9.52%19K | 162.50%63K | -36.84%12K | 3,600.00%37K |
| Net income | 15.45%-1.51M | 43.20%-1.86M | -28.40%-12.34M | -9.64%-5.33M | 16.93%-1.94M | -340.99%-1.79M | -63.00%-3.28M | -61.54%-9.61M | -41.16%-4.86M | -17.42%-2.34M |
| Net income continuous Operations | 15.45%-1.51M | 43.20%-1.86M | -28.40%-12.34M | -9.64%-5.33M | 16.93%-1.94M | -340.99%-1.79M | -63.00%-3.28M | -61.54%-9.61M | -41.16%-4.86M | -17.42%-2.34M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 15.45%-1.51M | 43.20%-1.86M | -28.40%-12.34M | -9.64%-5.33M | 16.93%-1.94M | -340.99%-1.79M | -63.00%-3.28M | -61.54%-9.61M | -41.16%-4.86M | -17.42%-2.34M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 15.45%-1.51M | 43.20%-1.86M | -28.40%-12.34M | -9.64%-5.33M | 16.93%-1.94M | -340.99%-1.79M | -63.00%-3.28M | -61.54%-9.61M | -41.16%-4.86M | -17.42%-2.34M |
| Basic earnings per share | 33.33%-0.28 | 46.84%-0.42 | -11.03%-2.92 | 4.55%-1.26 | 28.13%-0.46 | -281.82%-0.42 | -38.60%-0.79 | -30.20%-2.63 | -35.11%-1.32 | -7.86%-0.64 |
| Diluted earnings per share | 33.33%-0.28 | 46.84%-0.42 | -11.03%-2.92 | 4.55%-1.26 | 28.13%-0.46 | -281.82%-0.42 | -38.60%-0.79 | -30.20%-2.63 | -35.11%-1.32 | -7.86%-0.64 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg